Daniela Schmid

3PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 18, 2024
Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.

Aaron R Hansen, Carlos A Gomez-Roca, Debbie G J Robbrecht

|Apr 17, 2024
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors.

Neeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg

|Mar 23, 2018
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases.

Chun Gwon Park, Christina A Hartl, Daniela Schmid

Pageof 1

Frequent Collaborators

2 joint publications

Volker Teichgräber

2 joint publications

Christophe Boetsch

2 joint publications

Neeltje Steeghs

2 joint publications

Carlos Gomez-Roca